125 related articles for article (PubMed ID: 35914649)
1. Acid and Alkaline Phosphatases Specific activities and Expression as Biomarkers in Brain Tumor Grading and Correlation of Anaplastic Oligodendroglioma G-III to Meningiomas G-I among Brain Tumors and their primary culture.
Muddobalaiah P; Ravi V; Thammanna CC; Sagar BKC; Swamy NSR
J Chem Neuroanat; 2022 Nov; 125():102140. PubMed ID: 35914649
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
3. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
[TBL] [Abstract][Full Text] [Related]
4. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
Tsai WC; Hueng DY; Nieh S; Gao HW
J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434
[TBL] [Abstract][Full Text] [Related]
5. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
9. Expressions of Endocan in Patients with Meningiomas and Gliomas.
Atukeren P; Kunbaz A; Turk O; Kemerdere R; Ulu MO; Turkmen Inanir N; Tanriverdi T
Dis Markers; 2016; 2016():7157039. PubMed ID: 27528791
[TBL] [Abstract][Full Text] [Related]
10. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
11. Fatty Acid-binding Protein 4 Expression in Tumor Cells as a Potential Marker for Anaplastic Meningiomas.
Lee V; Smith TW; Arikan MÇ; Zhang L; Çataltepe O; Çataltepe S
Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):e10-e16. PubMed ID: 32324631
[TBL] [Abstract][Full Text] [Related]
12. Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy.
van Westen D; Lätt J; Englund E; Brockstedt S; Larsson EM
Acta Radiol; 2006 Apr; 47(3):311-9. PubMed ID: 16613314
[TBL] [Abstract][Full Text] [Related]
13. Paucity of retinoic acid receptor alpha (RAR alpha) nuclear immunostaining in gliomas and inability of retinoic acid to influence neural cell adhesion molecule (NCAM) expression.
Kleinschmidt-DeMasters BK; Orr EA; Savelieva E; Owens GC; Kruse CA
J Neurooncol; 1999 Jan; 41(1):31-42. PubMed ID: 10222420
[TBL] [Abstract][Full Text] [Related]
14. The expression of hypoxia-inducible factor-1 in primary brain tumors.
Reszec J; Rutkowski R; Chyczewski L
Int J Neurosci; 2013 Sep; 123(9):657-62. PubMed ID: 23550771
[TBL] [Abstract][Full Text] [Related]
15. E-Cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas.
Schwechheimer K; Zhou L; Birchmeier W
Virchows Arch; 1998 Feb; 432(2):163-7. PubMed ID: 9504862
[TBL] [Abstract][Full Text] [Related]
16. Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors.
Feichtinger RG; Weis S; Mayr JA; Zimmermann FA; Bogner B; Sperl W; Kofler B
Neuro Oncol; 2016 Feb; 18(2):184-94. PubMed ID: 26106125
[TBL] [Abstract][Full Text] [Related]
17. C-erbB2/HER2 in human gliomas, medulloblastomas, and meningiomas: a minireview.
Waage IS; Vreim I; Torp SH
Int J Surg Pathol; 2013 Dec; 21(6):573-82. PubMed ID: 23842006
[TBL] [Abstract][Full Text] [Related]
18. [Classification and grading of gliomas and meningiomas].
Niedermayer I; Kolles H; Feiden W
Radiologe; 1998 Nov; 38(11):888-97. PubMed ID: 9861648
[TBL] [Abstract][Full Text] [Related]
19. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
20. Meningioma: Signaling pathways and tumor growth.
Burnett BA; Womeldorff MR; Jensen R
Handb Clin Neurol; 2020; 169():137-150. PubMed ID: 32553285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
